Published in Gen Physiol Biophys on January 01, 2009
Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci (2011) 1.23
The annexin A2 system and vascular homeostasis. Vascul Pharmacol (2011) 1.14
Plasminogen receptors: the first quarter century. Semin Thromb Hemost (2013) 1.09
Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. J Biol Chem (2010) 0.96
The annexin A2/S100A10 system in health and disease: emerging paradigms. J Biomed Biotechnol (2012) 0.96
Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost (2013) 0.92
Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood (2011) 0.92
Dynamic reciprocity: the role of annexin A2 in tissue integrity. J Cell Commun Signal (2014) 0.90
New insights into the role of Plg-RKT in macrophage recruitment. Int Rev Cell Mol Biol (2014) 0.89
From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors. PLoS One (2014) 0.86
Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells. J Cell Sci (2013) 0.82
The Biology of Annexin A2: From Vascular Fibrinolysis to Innate Immunity. Trans Am Clin Climatol Assoc (2015) 0.80
Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. J Comp Neurol (2016) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol (2005) 5.71
Physiological consequences of loss of plasminogen activator gene function in mice. Nature (1994) 4.40
Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src. Mol Cell Biol (1986) 3.99
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
Molecular mechanisms of fibrinolysis. Br J Haematol (2005) 3.03
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98
Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry (1991) 2.66
Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med (1999) 2.65
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest (2004) 2.45
An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem (1994) 2.22
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem (1996) 2.13
Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol (1997) 1.94
Annexin II light chain regulates sensory neuron-specific sodium channel expression. Nature (2002) 1.88
Binding of plasminogen to cultured human endothelial cells. J Biol Chem (1986) 1.87
Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (1989) 1.85
Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. Proc Natl Acad Sci U S A (1985) 1.72
Identification of oxidant-sensitive proteins: TNF-alpha induces protein glutathiolation. Biochemistry (2000) 1.70
An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem (2004) 1.68
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1996) 1.66
An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem (1994) 1.65
LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUES. Br Med Bull (1964) 1.63
The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des (2007) 1.57
Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1. Circ Res (2008) 1.55
Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science (1989) 1.52
The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites. J Cell Sci (1992) 1.48
Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci (2002) 1.47
Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene (2003) 1.46
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release. Proc Natl Acad Sci U S A (2002) 1.42
Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem (1991) 1.36
Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci (2005) 1.36
Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood (2003) 1.32
Histone H2B as a functionally important plasminogen receptor on macrophages. Blood (2007) 1.29
Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest (1996) 1.29
Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays (1994) 1.29
Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J Biol Chem (2003) 1.26
Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J Biol Chem (1998) 1.25
Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem (2001) 1.24
In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci U S A (1992) 1.23
Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem (1991) 1.23
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J Biol Chem (2008) 1.22
Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol (1993) 1.18
Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood (2001) 1.16
Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest (1987) 1.15
Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest (1993) 1.13
Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior. J Neurosci (2006) 1.11
Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery. Circ Res (2001) 1.09
Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2. J Biol Chem (1996) 1.09
The role of annexin II tetramer in the activation of plasminogen. J Biol Chem (1998) 1.08
Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J Biol Chem (1990) 1.08
Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2. J Cell Sci (2003) 1.01
Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest (1986) 1.00
The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen. J Biol Chem (1991) 1.00
Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites. J Biol Chem (1988) 0.97
Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study. Brain Res (2007) 0.96
Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells. Biochem J (1987) 0.94
Protein kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells. Dependence on the elevation of messenger RNA. J Biol Chem (1989) 0.94
Modulation of annexin II by homocysteine: implications for atherothrombosis. J Investig Med (1998) 0.93
A new consensus sequence for phosphatidylserine recognition by annexins. J Biol Chem (2002) 0.93
Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator. J Biol Chem (1989) 0.92
Annexin II-mediated plasmin generation activates TGF-beta3 during epithelial-mesenchymal transformation in the developing avian heart. Dev Biol (2004) 0.90
Tyrosine phosphorylation of annexin II tetramer is stimulated by membrane binding. J Biol Chem (1997) 0.88
Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Blood (1989) 0.82
Nitration of annexin II tetramer. Biochemistry (2002) 0.81
Annexin II tetramer inhibits plasmin-dependent fibrinolysis. Biochemistry (1998) 0.80
Regulation of plasmin activity by annexin II tetramer. Biochemistry (2000) 0.80
The P11, tPA/plasminogen system and brain-derived neurotrophic factor: Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants. Med Hypotheses (2006) 0.79
The perivascular niche regulates breast tumour dormancy. Nat Cell Biol (2013) 3.36
Molecular mechanisms of fibrinolysis. Br J Haematol (2005) 3.03
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest (2004) 2.45
An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem (2004) 1.68
Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. J Biol Chem (2003) 1.49
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood (2013) 1.48
Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci (2002) 1.47
Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J Cereb Blood Flow Metab (2010) 1.44
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood (2006) 1.34
Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood (2003) 1.32
Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci (2011) 1.23
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J Biol Chem (2008) 1.22
The annexin A2 system and vascular homeostasis. Vascul Pharmacol (2011) 1.14
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood (2009) 1.13
Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest (2009) 1.04
Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation. PLoS One (2012) 1.04
Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. Mol Biol Cell (2009) 0.99
Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Gastroenterology (2010) 0.98
Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy. Stroke (2010) 0.98
Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. J Biol Chem (2010) 0.96
Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study. Brain Res (2007) 0.96
Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke (2010) 0.96
The annexin A2/S100A10 system in health and disease: emerging paradigms. J Biomed Biotechnol (2012) 0.96
Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost (2013) 0.92
Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB J (2006) 0.92
Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood (2011) 0.92
Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. Nat Commun (2012) 0.92
Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. J Cell Biochem (2003) 0.90
Annexin II-mediated plasmin generation activates TGF-beta3 during epithelial-mesenchymal transformation in the developing avian heart. Dev Biol (2004) 0.90
Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells. J Cell Sci (2013) 0.82
Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity. Thromb Haemost (2013) 0.81
Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis. Genesis (2014) 0.80
Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer. Anticancer Res (2002) 0.79
Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice. Am J Physiol Heart Circ Physiol (2011) 0.78
Aaron J. Marcus: in pursuit of perfection. J Clin Invest (2015) 0.75
Corrigendum: Annexin A2 promotes phagophore assembly by enhancing Atg16⁺ vesicle biogenesis and homotypic fusion. Nat Commun (2015) 0.75
The annexin A2 system and angiogenesis. Biol Chem (2016) 0.75